Fetal macrosomia (FM) is a well-recognized complication of diabetic pregnancy but it is not known whether placental transport mechanisms are altered. We therefore studied the activity of the system A amino acid transporter, the system L amino acid transporter, and the Na+/H+ exchanger in microvillous membrane vesicles from placentas of macrosomic babies born to diabetic women (FM group), from placentas of appropriately grown babies born to diabetic women (appropriate for gestational age group) and from placentas of appropriately grown babies of normal women (control group). Sodium-dependent uptake of ["'C]-methylaminoisobutyric acid at 30 s (initial rate, a measure of system A activity) was 49% lower into FM vesicles than into control vesicles (P < 0.02); this effect was due to a decrease in Vmax of the transporter with no change in Km. There was no significant difference in system A activity between the appropriate for gestational age group and control or FM group. There was also no difference between system L transporter or Na+/H+ exchanger activity between the three groups. We conclude that the number of system A transporters per milligram of membrane protein in the placental microvillous membrane is selectively reduced in diabetic pregnancies associated with FM. (J. Clin. Invest. 1994.
ylaminoisobutyric acid; MVM, microvillous membrane. of nutrients must be increased, but it is not known whether the activity of specific placental transport proteins is altered.
Pregnancy complicated by diabetes mellitus is a well known cause of FM (3, 4) . The incidence of FM in pregnant diabetic women remains high, despite improvements in their metabolic control, and can complicate up to 40% of such pregnancies (5) . The reasons for excessive fetal growth occurring in these pregnancies are not known. Pedersen (6) suggested that maternal hyperglycemia leads to fetal hyperglycemia and hence fetal hyperinsulinemia, which may then stimulate excessive intrauterine growth. However, it is well known that some diabetic women give birth to macrosomic babies despite satisfactory glycemic control during their pregnancy (7) . The Pedersen hypothesis was later expanded to include other metabolic fuels including amino acids (8) . Amino acids are important to the fetus, both as building blocks for tissue accretion and as a source of fuel for fetal oxidative catabolism (9) . However, the activity of amino acid transporters, or indeed of other transporters, in placentas of diabetic women with macrosomic babies has not been investigated.
The transcellular movement of amino acids across the syncytiotrophoblast, the main exchange barrier of the placenta, is mediated by specific transporters present on both the maternal facing microvillous plasma membrane (MVM) and the fetal facing basal plasma membrane (10). The Na+ -dependent system A transporter, present on both syncytiotrophoblast membranes, mediates the transport of neutral amino acids with short, polar, linear side chains. Its activity in the MVM is reduced by 50-60% in pregnancies associated with intrauterine growth retardation (11, 12) . The primary aim of this study was therefore to investigate whether the activity of this transporter is also altered in cases of FM arising from pregnancies complicated by maternal diabetes. Vesicles prepared from the MVM were used, and for comparison the activity of the Na+-independent system L amino acid transporter was also investigated.
The human placental syncytiotrophoblast has been shown to possess Na+/H+ exchanger activity, with that on the MVM resembling the NHE-1 isoform, whereas the basal membrane exchanger resembles the NHE-2 isoform ( 13) . The NHE-1 isoform is postulated to be associated with "housekeeping" functions such as cellular pH regulation (13) . The second aim of this study was therefore to determine whether there were any changes in MVM Na+/H+ exchanger activity in diabetic pregnancies associated with FM, a clinical situation where the metabolic requirements of both fetus and trophoblast are likely to be altered.
To separate effects of diabetes alone from those due to macrosomia, placentas from diabetic and nondiabetic women giving birth to appropriately grown babies were studied in addition to those from diabetic women giving birth to macrosomic babies.
Methods

Patient selection
This study was approved by the Central Manchester Health Authority Ethical Committee. Placentas from three groups of patients were studied. One group was a control group of women who had normal pregnancies and for whom there was no evidence to suggest undiagnosed diabetes. The birth weights in this group ranged between the 3rd and 90th centiles ( 14) . These women either had spontaneous vaginal deliveries (n = 11 ) or elective caesarean sections because of breech presentation or previous caesarean section (n = 7) and were chosen to allow study of a control vesicle preparation within 1-2 wk of that of a diabetic patient. A second group consisted of women with diabetes or impaired glucose tolerance (see below) giving birth, by vaginal delivery (n = 7), or elective (n = 4) or emergency (n = 1) caesarean section, to babies of normal birth weight (appropriate for gestational age (20) . The vesicles were also checked for contamination with intracellular organelles by assaying for succinate dehydrogenase and NADH dehydrogenase activities as mitochondrial and endoplasmic reticulum markers, respectively (21, 22) . The orientation of the vesicles was investigated by measuring alkaline phosphatase specific activity before and after permeabilizing the vesicles with 0.1% saponin (17 ['4C]Leucine uptake. The activity of the MVM system L amino acid transporter, which is Na+ independent (23, 24), was determined by measuring the uptake into MVM vesicles of [14C] leucine, an amino acid which is transported primarily by this system (10, 23), using a method similar to that described by Kudo and colleagues (23) ['4C ]leucine at room temperature to be too rapid to determine initial rate activity, and all uptakes reported here were performed at 4°C. Reactions were terminated at the appropriate times by addition of 2 ml ice-cold Krebs-Ringer phosphate solution (130 mM NaCl, 10 mM Na2HPO4, 4.2 mM KCl, 1.2 mM MgSO4, 0.75 mM CaCl2; titrated to pH 7.4 with 11.6 M HCl). 1 ml of this suspension was applied immediately to a millipore filter (presoaked in ice-cold Krebs-Ringer phosphate) and washed with 10 ml ice-cold Krebs-Ringer phosphate. Filters were placed in glass vials to which 2 ml 2-ethoxyethanol and 12 ml Optiphase "HiSafe II" liquid scintillation fluid (Pharmacia, Milton Keynes, UK) were added and counted in a liquid scintillation analyzer Sodium uptake. Sodium uptake into MVM vesicles was measured at room temperature using 22NaCl (Amersham) in the presence of an outwardly directed H + gradient and either with or without the presence of 0.5 mM amiloride in the EVB as described previously (12, 17) . The activity of the Na+/H+ exchanger was defined as the amiloride inhibitable component. Ion-exchange columns were used to separate extravesicular sodium-22, retained by the resin from intravesicular sodium-22, which was collected as the eluent (17, 25) . Radiolabel not Fig. 1 . As found previously ( 12) , uptake was initially rapid, but equilibrium was not finally achieved until 20-24 h, as reflected by the similarity in uptakes at 20 and 24 h (data not shown). Binding of ['4C] -MeAIB to the membranes, as measured after incubating the vesicles in the presence of triton, was < 2% of equilibrium uptake in all three groups (Fig. 1 ). There was a significant difference between uptake in the presence of an Na+ gradient to that in a K+ gradient at all time points up to 120 min. The uptakes were linear over the first minute of the reaction so that, for comparison purposes, measurements at 30 s were taken to represent the initial rate. As shown in Table HI, the initial uptake by the FM vesicles in the presence of an Na + gradient, but not that in the presence of a K+ gradient, was significantly lower than that into the control vesicles. Consequently, the calculated initial rate of uptake due to the Na '-dependent system A transporter (the difference between that in the presence of an Na+ gradient and that in the presence of a K+ gradient) was 49% lower in the FM than in the control vesicles (Table Ill) . Initial uptakes of ['4C] MeAIB by the AGA vesicles were not significantly different from those by the control or FM vesicles. Equilibrium (24 h) uptakes were not significantly different between any of the three groups (0.587+0.097 nmol/mg protein, n = 10; 0.483±0.185 nmol/mg protein, n = 3; 0.653±0.110 nmol/mg protein, n = 9; control, AGA, and FM groups, respectively).
As control and FM groups showed a significant difference in system A transporter activity, transporter kinetics were compared between these two groups. Initial rate of Na+ -dependent MeAIB uptake in four preparations each of control and FM vesicles is plotted against MeAIB concentration in Fig. 2 . Vm.,, calculated from these plots, was significantly (P < 0.02) lower in the FM group as compared with the control group (0.47±0.07 vs 0.96±0.13 nmol/mg protein per 30 s, respectively), but there was no significant difference in Km (2.10+1.08 vs 1.44+0.80 mM, respectively).
['4C]Leucine uptake by vesicles. The early time course of ['4C] leucine uptake by the three groups of vesicles is shown in Fig. 3 . As can be seen, despite measurements being made at 4°C, uptake appeared to start to plateau at 5 s, but this was similar for all three groups. [ "C I Leucine uptake in the presence of excess unlabeled leucine was < 10% of total uptake ( Fig. 3 and Table IV ), suggesting that the majority of uptake was via Values are mean±SE (n). Uptakes are shown for Na+ and K+ gradients and also for that due specifically to the system A transporter ("A"), calculated as the difference between the former two. * P < 0.01; t P < 0.02 compared with control group; ANOVA with Scheffe.
the system L transporter. Binding of ["4C]leucine to the membranes, as measured in the presence of triton, was < 7% of equilibrium uptake in all three groups. 3-s uptake was taken as giving an approximation of initial rate, and these data are shown in Table IV for total, nonmediated (excess unlabeled leucine), and system L (the difference between total and nonmediated) mediated uptake. There was no difference in any of these variables between the three groups. Equilibrium (24 h; there was no difference in uptake between 2-and 24-h measurements) uptake was also not different between the three groups. Na+ uptake by vesicles. The percentage of vesicles recovered in the eluent from the ion-exchange columns was similar in control (46±2%, n = 9), AGA (52±3%, n = 7), and FM (48+2%, n = 7) groups.
The time courses for Na+ uptake by the vesicles are shown in Fig. 4 . As found previously ( 12, 17) in the absence of amiloride, Na' uptake is initially rapid and is accompanied by an overshoot at 5-10 min. This is followed by an efflux of Na+, and equilibrium is reached by 2 h, as reflected by the similarity in uptakes at 2 and 24 h (data not shown). Binding of sodium-22 to the membranes, as measured in the presence of triton, MeAIB concentration (mmol/l) Figure 2 . Kinetics of MeAIB uptake by control (-) and FM (A) vesicles. Initial rate (30 s) uptake of MeAIB in the presence and absence of Na + was measured, as in Fig. 1 , over a range of MeAIB concentrations in the EVB. Data were obtained from four placentas each in the two groups shown. Na+-dependent uptake (the difference between that in the presence and that in the absence of Na+) has been plotted, as individual data points (one at each concentration from each placenta) against MeAIB concentration, and the data were fitted by nonlinear regression to the Michaelis-Menten equation to allow calculation of Vl,, and Km. mM leucine, 5 mM Hepes, 5 mM Tris; titrated to pH 7.4 with 11.6 M HCO and to which [L-'4C] leucine was added so that the final radioactive leucine concentration was 20 AM). The reaction was terminated at the intervals shown by adding 2 ml of ice-cold KrebsRinger phosphate solution. 1 ml was immediately filtered through presoaked millipore filters (0.45 ym) and washed with 10 ml of Krebs-Ringer phosphate solution. Values shown are mean±SE for vesicle preparations from five to six placentas in the control group, four placentas in the AGA group, and four to five placentas in the FM group. * is total uptake data; A is uptake in the presence of excess unlabeled leucine.
Values are mean±SE. C, control, n = 6; AGA, n = 4; FM n = 5. * Total uptake of ['4C]leucine; Excess leucine is the uptake of ['4C]leucine in the presence of 50 mM unlabeled leucine in the EVB, and "L" is the difference between the two representing uptake by the system L transporter.
was < 2% for all three groups (Fig. 4) . Uptake in the presence of amiloride was significantly lower than that in its absence at all time points up to 60 min. Both total and amiloride-insensitive Na+ uptakes were linear over the first minute. In addition, the amiloride-sensitive Na' uptake (calculated as the difference between that in the presence and absence of amiloride) was also linear over the first minute. For comparison purposes, therefore, the uptake at 30 s was taken to represent an initial rate. The initial and equilibrium uptakes are shown in Table V ; there were no significant differences between any of the groups.
Discussion
This study provides the first report on placental MVM transporter activity in relation to fetal overgrowth and diabetes in women. System A transporter activity was significantly and markedly lower in the MVM from placentas of FM babies from diabetic pregnancies as compared with MVM of control pregnancies. The significantly lower V,,, but not Km of this transporter in the FM group as compared with the control group suggests that the number of transporters was reduced. Furthermore, the lack of difference in either system L or Na+/H+ exchanger activity between the three groups suggests that the effect on system A is quite selective. Less clear-cut is the effect of diabetes per se on system A activity. We failed to find a significant difference in system A transporter activity of MVM from placentas of AGA babies from diabetic pregnancies as compared with control or as compared with MVM from placentas of FM babies. Although this, together with a previous report that there is no change in the total uptake of aminoisobutyric acid by MVM from placentas of diabetic pregnancies with normal fetal growth as compared with normal pregnancies ( 11) , suggests that reduced transporter activity may be primarily related to macrosomia rather than diabetes (especially as in the present study there was no difference in the glycemic control achieved in the two diabetic groups). Clarification of this point awaits study of placentas of macrosomic babies born to patients shown definitively not to have diabetes or impaired glucose tolerance during pregnancy.
The placentas in the FM group were of a slightly but significantly lower gestation than in the control group. Higher Na'-dependent uptake of L-alanine by late gestation (37) (38) wk) human placental MVM vesicles as compared with early gestation (12-13 wk) MVM vesicles has been described (26). Values are mean±SE. C, control, n = 12; AGA, n = 8; FM, n = 10.
* Total uptake of Na' in the absence of amiloride; the uptake by the Naf/H' exchanger is calculated as the difference between the total uptake and the uptake in the presence of 0.5 mM amiloride.
of gestation was -4 wk.). We therefore believe that the lower system A activity in the FM group was not a result of gestational differences per se.
As system A activity is reduced in MVM from placentas of growth-retarded babies ( 11, 12) , the finding here that it is similarly reduced in FM was somewhat surprising, although in streptozotocin-induced, mildly diabetic pregnant rats giving birth to macrosomic fetuses, fetal plasma amino acids have been shown to be reduced despite normal maternal concentrations (27) .
For the physiological significance of our data on the system A transporter to be determined, a number of other factors need to be taken into consideration. Transcellular amino acid net flux across the placenta in vivo will be dependent on: (a) the activities and numbers of transporters in both the microvillous and basal plasma membranes of-the syncytiotrophoblast and the balance between maternofetal and fetomaternal flux; included in this will be the surface area of plasma membrane; (b) maternal and fetal plasma concentrations of amino acids; the importance of this will be dependent on the Km of transporters; (c) for Na+-dependent electrogenic transfer, as occurs with the system A transporter, membrane potential and any transplacental potential difference will be important (28); and (d) syncytiotrophoblast amino acid metabolism (29) .
Our kinetic data suggest that the system A transporter is not saturated at physiological concentrations of its substrates. Therefore, raised maternal plasma concentrations as may occur in diabetes (30, 31 ) would be likely to increase flux of substrate via the transporter opposing its apparent downregulation. Furthermore, there is a hint that syncytiotrophoblast plasma membrane surface area is increased in diabetes (32) . However, nothing is known about the electrophysiology of the human diabetic placenta or of its amino acid metabolism.
Therefore, we currently have insufficient information to establish whether in vivo substrate flux via the system A transporter in the MVM of the FM placenta in diabetes near term reflects its lower in vitro activity per milligram of membrane protein. However, it does seem more likely that the latter is an adaptation to macrosomia, rather than it being important in its genesis.
The placenta is rich in insulin receptors on the MVM (33). The effects of diabetes on placental insulin receptors have been variably reported as no change, decreased, and increased concentrations (34) (35) (36) . The reports on insulin effects on placental amino acid transport are also conflicting with some reporting no change (37) and others demonstrating stimulation of uptake (38, 39) . Therefore, it is not possible to determine the role of insulin in the changes in transporter activity which we have observed, although this does seem to be a likely mediator of the effect.
In conclusion, this investigation has demonstrated that placental MVM system A transporter activity is selectively reduced when diabetic pregnancy results in FM, probably due to a decrease in the number of transporters.
